Evidence map›Paper›PMID 23144238›Full record

ArticleMolecular pharmacology2013

Noncompetitive, voltage-dependent NMDA receptor antagonism by hydrophobic anions.

Andrew J Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F Zorumski, Steven Mennerick

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Quetiapine competitively inhibits 5-HTThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Article
  2. Review
  3. A dark quencher genetically encodable voltage indicator (dqGEVI) exhibits high fidelity and speed.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Andrew J LinsenbardtDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Mariangela Chisari
Andrew Yu
Hong-Jin Shu
Charles F Zorumski
Steven Mennerick
University of Catania · ITWashington University in St. Louis · US

Funding

STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUESP01GM047969 · NIGMS · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 1992 to 2011
$18.7M
BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · NIDA · WASHINGTON UNIVERSITY · PI ARPANA AGRAWAL, Jose A Moron-Concepcion · 1991 to 2026
$8.8M
CONTROL OF SYNAPTIC GLUTAMATE RELEASER01MH078823 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2015
$3.2M
MODULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITYR01MH077791 · NIMH · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2007 to 2013
$2.4M
ETHANOL, NEUROSTEROIDS & HIPPOCAMPAL PLASTICITYR01AA017413 · NIAAA · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2009 to 2013
$1.8M
NIAAA NIH HHS AA017413NIAAA NIH HHS R01 AA017413NIDA NIH HHS DA07261NIDA NIH HHS T32 DA007261NIGMS NIH HHS GM47969NIGMS NIH HHS P01 GM047969NIMH NIH HHS MH 077791NIMH NIH HHS MH078823NIMH NIH HHS R01 MH077791NIMH NIH HHS R01 MH078823
6 · The paper itself

Abstract

NMDA receptor (NMDAR) antagonists are dissociative anesthetics, drugs of abuse, and are of therapeutic interest in neurodegeneration and neuropsychiatric disease. Many well-known NMDAR antagonists are positively charged, voltage-dependent channel blockers. We recently showed that the hydrophobic anion dipicrylamine (DPA) negatively regulates GABA(A) receptor function by a mechanism indistinguishable from that of sulfated neurosteroids. Because sulfated neurosteroids also modulate NMDARs, here we examined the effects of DPA on NMDAR function. In rat hippocampal neurons DPA inhibited currents gated by 300 µM NMDA with an IC(50) of 2.3 µM. Neither onset nor offset of antagonism exhibited dependence on channel activation but exhibited a noncompetitive profile. DPA antagonism was independent of NMDAR subunit composition and was similar at extrasynaptic and total receptor populations. Surprisingly, similar to cationic channel blockers but unlike sulfated neurosteroids, DPA antagonism was voltage dependent. Onset and offset of DPA antagonism were nearly 10-fold faster than DPA-induced increases in membrane capacitance, suggesting that membrane interactions do not directly explain antagonism. Furthermore, voltage dependence did not derive from association of DPA with a site on NMDARs directly accessible to the outer membrane leaflet, assessed by DPA translocation experiments. Consistent with the expected lack of channel block, DPA antagonism did not interact with permeant ions. Therefore, we speculate that voltage dependence may arise from interactions of DPA with the inherent voltage dependence of channel gating. Overall, we conclude that DPA noncompetitively inhibits NMDA-induced current by a novel voltage-dependent mechanism and represents a new class of anionic NMDAR antagonists.

Indexed as

AnimalsAnionsCell LineFemaleHEK293 CellsHippocampusHumansHydrophobic and Hydrophilic InteractionsNeuronsNeurotransmitter AgentsN-MethylaspartateOocytesPicratesRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateAnionsdipicrylamineNeurotransmitter AgentsN-MethylaspartatePicratesReceptors, N-Methyl-D-Aspartate

Identifiers

PMID23144238
PMCPMC3558806
OpenAlexW2150210824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.